Analystreport

Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Madrigal Pharmaceuticals, Inc.  (MDGL) 
Last madrigal pharmaceuticals, inc. earnings: 2/26 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: madrigalpharma.com